Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms

Por Nakaya, Y, Shide, K, Niwa, T, Homan, J, Sugahara, S, Horio, T, Kuramoto, K, Kotera, T, Shibayama, H, Hori, K, Naito, H, Shimoda, K
Publicado em 2011